2013
DOI: 10.1016/j.intimp.2013.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 31 publications
0
8
0
Order By: Relevance
“… 50 IDO activation is suggested to ameliorate GvHD severity and mortality. 56 58 High expression of IDO in intestinal mucosal mononuclear cells and low expression in endothelial cells were associated with favorable outcome in intestinal GvHD. 59 In our study, we could find higher IDO expression levels after allogeneic BMT in both HIP and LIP animals.…”
Section: Discussionmentioning
confidence: 98%
“… 50 IDO activation is suggested to ameliorate GvHD severity and mortality. 56 58 High expression of IDO in intestinal mucosal mononuclear cells and low expression in endothelial cells were associated with favorable outcome in intestinal GvHD. 59 In our study, we could find higher IDO expression levels after allogeneic BMT in both HIP and LIP animals.…”
Section: Discussionmentioning
confidence: 98%
“…50 IDO activation is suggested to ameliorate GvHD severity and mortality. [56][57][58] High expression of IDO in intestinal mucosal mononuclear cells and low expression in endothelial cells were associated with favorable outcome in intestinal GvHD. 59 In our study, we could find higher IDO expression levels after allogeneic BMT in both HIP and LIP animals.…”
Section: Discussionmentioning
confidence: 96%
“…As reviewed by Murakami et al 11 , the immunosuppressive effect of IDO results from inhibited T cell proliferation by local depletion of trp, the apoptotic properties of trp metabolites such as 3-hydroxykynurenine (3-HK) and 3-hydroxyanthranilic acid (3-HAA) on T cells, and the ability of IDO to activate mature regulatory T cells (Tregs) and to convert naive T cells to Tregs. In animal models of GVHD, IDO activation is suggested to ameliorate disease severity and reduce mortality 1719 . In GVHD in humans, kyn urine levels as a marker of IDO activity correlate with disease severity.…”
Section: Discussionmentioning
confidence: 99%